Topics:

Susan Kweskin

Susan Kweskin

Susan Kweskin is Group Editorial Director of Psychiatric Times and www.PsychiatricTimes.com. She is also Editorial Director of www.Consultantlive.com, a site dedicated to primary care physicians. Email here.

Linkedin

Posts by Author

A look around the web at breaking news -- not all of it medical.

Was the business of the heart always so heartless?

Microbes in the gut affect metabolic pathways involved in the pathogenesis of obesity, insulin resistance, and diabetes. Antibiotics can alter gut microbiota.

Aflibercept (Eylea, Regeneron Pharmaceuticals), a second ophthalmic vascular endothelial growth factor inhibitor, has received FDA approval for the treatment of diabetic retinopathy in patients with diabetic macular edema.

Three questions for you about this week's breaking medical news on the risks of sitting still, diabetic eye disease, and antibiotics and insulin resistance.

In the past few months, the FDA has approved a number of drugs for a variety of primary care disorders. Here’s a look at 11 of the newest.

DSM

What is known—and what is not known—about the clinical use of the DSM?

Is it okay for the media to show terrorist-sponsored torture videos? Are there no psychological effects of this kind of “show”?

If your patient asks you whether it is safe for him to get out there and shovel, here are some tips from the American Heart Association you might want to pass along.

The number of measles cases has hit an all time high since it was declared to be eliminated in the US back in 2000. Here's why.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.